Zhongzhen Yi
- Oncology top 2%
- CAR-T cell therapy research 14
- Cancer Immunotherapy and Biomarkers 2
- Viral-associated cancers and disorders 1
- Immunology top 5%
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 5
- Genetics top 10%
- Virus-based gene therapy research 3
- Genetics top 10%
- Virus-based gene therapy research 3
- Biomedical Engineering top 10%
- Nanowire Synthesis and Applications 5
-
- CRISPR and Genetic Engineering 1
- Co-authors
- Stephen GottschalkHao LiuGiedre KrenciuteMeng-Fen WuBrooke PrinzingGianpietro DottiKevin ChowIrina V. Balyasnikova
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Zhongzhen Yi
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 40
- Oncology 1.0k
- Immunology 459
- Genetics 145
- Genetics 294
- Biomedical Engineering 418
Countries citing papers authored by Zhongzhen Yi
This map shows the geographic impact of Zhongzhen Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongzhen Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongzhen Yi more than expected).
Fields of papers citing papers by Zhongzhen Yi
This network shows the impact of papers produced by Zhongzhen Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongzhen Yi. The network helps show where Zhongzhen Yi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongzhen Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 12 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 89 | |
| 8 | 2018 | 94 | |
| 9 | 2018 | 65 | |
| 10 | 2017 | 255 | |
| 11 | 2017 | 220 | |
| 12 | 2017 | 34 | |
| 13 | 2017 | 1 | |
| 14 | 2014 | 63 | |
| 15 | 2012 | 196 | |
| 16 | 2011 | 5 | |
| 17 | 2011 | 131 |
About Zhongzhen Yi
Zhongzhen Yi is a scholar working on Oncology, Immunology and Biomedical Engineering, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (6 papers), Nanowire Synthesis and Applications (5 papers), Immune Cell Function and Interaction (5 papers), Virus-based gene therapy research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Viral-associated cancers and disorders (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Oncology (1.0k citations), Immunology (459 citations) and Genetics (145 citations). Zhongzhen Yi has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Stephen Gottschalk, Hao Liu, Giedre Krenciute, Meng-Fen Wu, Brooke Prinzing, Gianpietro Dotti, Kevin Chow, Irina V. Balyasnikova, Donald R. Shaffer and Sunitha Kakarla. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.